New Delhi: Two years after actor Sushant Singh Rajput’s death by suicide, the Narcotics Control Bureau (NCB) on Wednesday filed draft charges against actress Rhea Chakraborty, her brother Showik and others before a special court, reported news agency PTI.
Special public prosecutor Atul Sarpande said the prosecution maintained charges against all the accused as mentioned in the charge sheet filed before the court, the report added.
The prosecution has proposed the court charge Rhea and Showik for consumption of narcotic substances and also for procuring and paying for such substances for Sushant. Sarpande said the court was scheduled to frame charges against all the accused. However, it couldn’t be done as a few of the accused moved discharge applications.
The court said that the charges would be framed only after the discharge pleas are decided. All the accused, including Rhea and Showvik, were present before the court on Wednesday, the agency reported quoting Sarpande.
Special judge V G Raghuwanshi, hearing cases pertaining to the Narcotic Drugs and Psychotropic Substances (NDPS) Act, posted the matter for hearing on July 12.
Rhea, her brother Showik Chakraborty and several others are arraigned as accused in the case for alleged consumption, possession and financing of drugs. Most of them are out on bail.
The CBI is probing the case pertaining to his death.
Mumbai: Social media platform X (formerly Twitter) has permanently suspended actress Swara Bhasker’s account for… Read More
Bhubaneswar: Even after the Utkarsh Odisha Conclave, the state continued to attract significant investment interest… Read More
Washington: It’s just over 12 hours since the US witnessed one of its worst air… Read More
Washington: As morning dawned in the American capital after a disastrous night, hopes of rescuing anyone… Read More
Mumbai: Model Poonam Pandey was one among millions of devotees who gathered at the Mahakumbh… Read More
Bhubaneswar: The Odisha government has accepted a proposal of SUM Health Care Services for setting… Read More
This website uses cookies.